Rovi Corporation (NASDAQ:ROVI) saw its shares take a beating after an appeals court decision went in favor of Amazon.com, Inc. (NASDAQ: AMZN). Rovi Corporation (NASDAQ:ROVI) shares after opening at $23.22 moved to $23.42 on last trade day and at the end of the day closed at $20.50. Company price to sales ratio in past twelve months was calculated as 3.68 and price to cash ratio as 3.79. Rovi Corporation (NASDAQ:ROVI) showed a negative weekly performance of -13.06%.
RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 250 owned and/or operated outpatient imaging centers, announced the expiration and final results of its previously announced cash tender offer for any and all of its outstanding $200,0000,000 aggregate principal amount of 10 3/8% Senior Notes due 2018 (the “Notes”) and the related solicitation of consents to amend the indenture governing the Notes (the “Consent Solicitation”). RadNet Inc. (NASDAQ:RDNT) shares advanced 9.84% in last trading session and ended the day on $4.13. RDNT return on assets ratio is recorded as 0.30% and. RadNet Inc. (NASDAQ:RDNT) yearly performance is 49.64%.
Ohr Pharmaceutical (NASDAQ:OHRP) shares dropped 16.75% to $10.02 after the company announced a 1.8 million share offering at $10 per share. OHR Pharmaceutical Inc (NASDAQ:OHRP) shares moved down -18.20% in last trading session and was closed at $9.84 while trading in range of $9.70 – 10.57 – OHR Pharmaceutical Inc (NASDAQ:OHRP year to date (YTD) performance is 24.87%.
Chapel Hill drug developer Pozen . (NASDAQ:POZN) submitted an additional study to the FDA and says it is on track to hear a ruling on two drug applications by the April 25 deadline. POZEN Inc. (NASDAQ:POZN) weekly performance is 3.78%. On last trading day company shares ended up $8.52. POZEN Inc. (NASDAQ:POZN) distance from 50-day simple moving average (SMA50) is 4.98%. Analysts mean target price for the company is $9.00.
Leave a Reply